Synovial sarcoma is thought to be driven mainly by a specific genetic accident inside cells, not by anything a person knowingly did or inherited from their parents.

What actually causes synovial sarcoma?

The core cause is a characteristic DNA change (a chromosomal translocation) inside a single cell. In more than 90–95% of cases, pieces of chromosome X and chromosome 18 swap places, creating an abnormal fusion gene called SS18::SSX (often involving SSX1 or SSX2). This fusion gene produces a protein that hijacks normal gene regulation and pushes the cell toward uncontrolled growth, eventually forming a tumor.

Doctors do not yet know why this translocation happens in the first place in most people. It is considered a somatic mutation, meaning it arises in the body’s cells during life and is not usually inherited or passed on to children like classic “family cancer genes.”

Known biology vs. “cause”

When people ask “what causes synovial sarcoma,” there are really two layers:

  • What is happening in the cell?
  • What triggered it in real life?

At the cell level:

  • A normal connective-tissue cell acquires the X–18 translocation t(X;18)(p11;q11)t(X;18)(p11;q11)t(X;18)(p11;q11), forming the SS18::SSX fusion oncogene.
  • The fusion protein binds to chromatin‑remodeling complexes (like the SWI/SNF/BAF complex) and disrupts how genes are switched on and off, leading to malignant transformation over time.
  • Additional smaller mutations and epigenetic changes accumulate and help the tumor grow and spread, but the fusion is considered the main “driver.”

In real‑life terms, however, for most patients there is no clear, single trigger such as an infection or a specific lifestyle choice.

Risk factors (what might raise the odds)

Having a risk factor does not mean someone will definitely develop synovial sarcoma; many patients have no identifiable risk factor at all. Still, some patterns show up in research and clinical practice:

  • Age pattern
    • More common in teenagers and young adults, often diagnosed before age 35.
* Can occur at any age, including children and older adults, but this is less typical.
  • Previous radiation therapy
    • A history of radiation treatment for another cancer can slightly increase the risk of various soft‑tissue sarcomas, including synovial sarcoma, after a latency period of several years.
  • Chemical exposures
    • Long‑term or heavy exposure to certain industrial or medical chemicals such as vinyl chloride, arsenic, and thorium dioxide has been linked with higher rates of soft‑tissue sarcoma and is listed as a possible risk factor for synovial sarcoma specifically.
  • Chronic lymphedema (persistent swelling)
    • Long‑standing swelling of an arm or leg (for example after lymph‑node surgery or radiation) is associated with some soft‑tissue sarcomas and is sometimes cited as a risk factor in synovial sarcoma FAQs.
  • Inherited cancer syndromes (rare)
    • Most synovial sarcomas are not hereditary, but some inherited conditions that predispose to many kinds of sarcoma (such as Li‑Fraumeni syndrome or neurofibromatosis type 1) may slightly increase the overall sarcoma risk, and are occasionally mentioned among potential risk factors.

Even with these links, for a given individual it is usually impossible to say “this is the exact thing that caused your synovial sarcoma.”

What does not seem to cause it?

Current evidence suggests:

  • No proof that everyday minor injuries, single bumps, or normal exercise trigger synovial sarcoma, even if symptoms are first noticed after a trauma.
  • No strong data that typical diet, moderate physical activity, or common infections directly cause this specific tumor type.
  • Most patients have no strong family history of sarcoma, supporting that the key mutation is acquired, not inherited.

“Latest news” & discussion trends

Recent reviews and expert guidelines still emphasize that the SS18::SSX fusion is the central driver and that the original trigger for the translocation remains unknown. Current research and headlines around synovial sarcoma focus more on:

  • Targeted treatments that exploit the biology of the SS18::SSX fusion and its effect on chromatin‑remodeling complexes.
  • Immunotherapy trials and personalized approaches for this rare cancer, which are frequently discussed in specialist centers and patient communities.

On forums and support groups, people often ask “why me?” and share possible exposures or injuries they worry about. Clinicians generally respond that while certain factors might raise risk, in most cases synovial sarcoma appears to be a random, unlucky genetic event in a single cell rather than something anyone caused by their choices.

TL;DR:
Synovial sarcoma is caused by a specific chromosome swap between X and 18 that creates the SS18::SSX fusion gene and drives cancer growth, but what triggers that DNA mistake in most people is still unknown. Environmental exposures, prior radiation, and some rare inherited syndromes can increase risk, yet many patients have no clear risk factor at all.

Information gathered from public forums or data available on the internet and portrayed here.